A Study of the Safety and Tolerance of Regadenoson in Subjects With Renal Impairment

NCT00863707 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

511

Enrollment

INDUSTRY

Sponsor class

Conditions

Kidney Diseases
Coronary Artery Disease

Interventions

DRUG: Regadenoson
DRUG: Placebo

Sponsor

Astellas Pharma Inc